Bizarre Patents
A method for inducing cats to exercise consists of directing a beam of invisible light produced by a hand-held laser apparatus onto the floor or wall.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 5955422 | Production of erthropoietin Disclosed are novel polypeptides possessing part or all of the primary structural conformation and one or more of the biological properties of mammalian erythropoietin ("EPO") which are characterized in preferred forms by being the product of procaryotic ... | 09/21/1999 |
| 5824778 | Chemically-modified G-CSF The present invention provides a chemically-modified protein prepared by binding polyethylene glycol to a polypeptide characterized by being the product of expression by a host cell of an exogenous DNA sequence and substantially having the following amino... | 10/20/1998 |
| 5621080 | Production of erythropoietin Disclosed are novel polypeptides possessing part or all of the primary structural conformation and one or more of the biological properties of mammalian erythropoietin ("EPO") which are characterized in preferred forms by being the product of procaryotic ... | 04/15/1997 |
| 5618698 | Production of erythropoietin Disclosed are novel polypeptides possessing part or all of the primary structural conformation and one or more of the biological properties of mammalian erythropoietin ("EPO") which are characterized in preferred forms by being the product of procaryotic ... | 04/08/1997 |
| 5597562 | Oral dosage form of biologically active proteins An oral dosage form comprising: (a) granulocyte colony stimulating factor or erythropoietin; (b) surfactant(s); (c) fatty acid(s); and (d) enteric material. The oral drug preparations provided by the present invention avoid inactivation of the principal i... | 01/28/1997 |
| 5552286 | Hybridoma cell lines and their monoclonal antibodies to human pluripotent granulocyte colony stimulating factor Murine-derived hybridoma tumor cell lines and monoclonal anti-human pluripotent Granulocyte Colony Stimulating Factor antibody substances produced by these cell lines. Use of said monoclonal antibody substances, alone or in combination, in immunological p... | 09/03/1996 |
| 5547933 | Production of erythropoietin Disclosed are novel polypeptides possessing part or all of the primary structural conformation and one or more of the biological properties of mammalian erythropoietin ("EPO") which are characterized in preferred forms by being the product of procaryotic ... | 08/20/1996 |
| 5441868 | Production of recombinant erythropoietin Disclosed are novel polypeptides possessing part or all of the primary structural conformation and one or more of the biological properties of mammalian erythropoietin ("EPO") which are characterized in preferred forms by being the product of procaryotic ... | 08/15/1995 |
| 5264209 | Modified HIL-6 Provided are PEGylated "interleukin-6" derivatives (PEG IL-6) having an extended plasma half-life, as well as enhanced in-vivo IL-6 biological activities. Methods for producing the modified glycosylated and unglycosylated IL-6 proteins or polypeptides, as... | 11/23/1993 |
| 4667016 | Erythropoietin purification Chromatographic procedures are individually and jointly applied to the rapid and efficient isolation of biologically active proteins and especially glycoproteins such as recombinant erythropoietin present in the medium of growth of genetically transformed... | 05/19/1987 |
| 4558006 | A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin Disclosed is a new mouse-mouse hybridoma tumor cell line A.T.C.C. No. HB8209. A monoclonal antibody produced by said cell line is specifically immunologically reactive with erythropoietin and with a polypeptide whose amino acid sequence is substantially d... | 12/10/1985 |
